UK: +442081254005
  • Middle East and Africa Neuromodulation Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Technology (External (Non-Invasive) Neuromodulation, and Internal Neuromodulation); Application (Chronic Pain Management, Failed Back Syndrome, Epilepsy, Tremor, Incontinence, Depression, Dystonia, Gastroparesis, Parkinson’s Disease, Obsessive-Compulsive Disorder, and Migraine); End User (Hospitals, Clinics, and Home Healthcare) and Geography

  • TIPRE00016325 | Single User License | $3000
Single User License

Subtotal $3000

Grand Total $3000

Credit Card/Debit Card

(credit/debit card)